Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Dale Terasaki to Substance Withdrawal Syndrome

This is a "connection" page, showing publications Dale Terasaki has written about Substance Withdrawal Syndrome.

 
Connection Strength
  
 
 
2.623
  
  1. Terasaki D, Kulick B, Calcaterra S, Ray L. Phenobarbital for alcohol withdrawal in the context of the opioid epidemic: a neglected caveat. Addiction. 2023 07; 118(7):1198-1200.
    View in: PubMed
    Score: 0.740
  2. Terasaki D, Brady J. Severe, Nondelirium Agitation as an Underreported Characteristic of Precipitated Fentanyl Withdrawal: A Case Report. J Addict Med. 2023 Jan-Feb 01; 17(1):111-113.
    View in: PubMed
    Score: 0.705
  3. Terasaki D, Klie K. Tramadol Withdrawal in the Setting of Buprenorphine Induction: A Case Report. J Addict Med. 2020 May/Jun; 14(3):264-266.
    View in: PubMed
    Score: 0.603
  4. Terasaki D, Smith C, Calcaterra SL. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy. 2019 10; 39(10):1023-1029.
    View in: PubMed
    Score: 0.574
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)